Synopsis:- India’s ports sector is gaining momentum, with brokerages highlighting 30–37% upside potential across leading players. One offers scale, a strong balance sheet, and steady 8% volume growth, while the other promises faster expansion through aggressive capex,...
Synopsis: Cipla’s Q3 net profit fell 57% YoY to Rs. 674 cr due to a Rs. 1,107 cr acquisition of diabetes drug rights and a Rs. 276 cr rise in gratuity and leave liabilities under India’s new labour codes. This is one of the leading Indian pharmaceutical companies...
Synopsis:- A PSU stock remained in focus after the government deferred a planned OFS to the next financial year. Shares rose 1.1%, with market capitalisation at ₹5.18 lakh crore. The Centre holds 96.5% stake, while SEBI has set a May 2027 deadline to raise public...
SYNOPSIS: HPCL reported strong Q3 FY26 growth with higher revenues and profits, robust refining operations and expansion, while brokerages remained mixed amid margin pressures, valuation concerns and long-term earnings support outlook. Shares of a Maharatna company...
Synopsis:- Shares moved 7% after a strong Q3FY26, driven by 201% YoY revenue growth and 73% profit rise. Quick commerce contributed 75% ( Rs 12,256 crore), with NOV up 121% YoY. Management targets 3,000–4,000 stores by FY27, signaling sustained hyper-growth momentum....
Synopsis: Companies set to announce December-quarter results today include Premier Energies, Adani Total Gas, Adani Energy, APL Apollo, Radico Khaitan, DLF, Coforge, Mphasis, Bandhan Bank, Go Digit, and Aditya Birla Sun Life AMC Limited. Several companies are set to...
Synopsis: Prabhudas Lilladher recommends Havells, JSW Infrastructure, JB Chemicals, JK Cement, Can Fin Homes, and MRPL as quality stocks, offering strong fundamentals and growth potential of up to 26%. Prabhudas Lilladher has identified a select set of stocks that...
Synopsis: Eternal CEO Deepinder Goyal resigns to pursue high-risk ventures; Q3 FY26 revenue jumps 201% YoY, driven by quick commerce, food delivery, and B2B supplies. The shares of the company, engaged in online food ordering and delivery, restaurant search and...
Synopsis: Jefferies has a Buy call on Sun Pharma, citing a potential 30% upside driven by the Organon acquisition, though higher leverage and limited R&D gains pose key risks. This large-cap Pharma Stock, engaged in developing, manufacturing, and marketing generic...
Synopsis: SRF Ltd is in focus after its Q3 results, with revenue rising 6% YoY to ₹3,713 crore and net profit surging 60% YoY to ₹433 crore in Q3 FY26 along with brokerage views on the results and operations. The shares of the Chemical company specialising in...
